(Date:10/6/2008)...t. 6 /PRNewswire/ -- Developed in collaboration wi...ades, CA is introducing,Revolutionary Breast Surfa...c Surgery office of Dr. Steve Laverson this week i...he first of its kind, and is based on,breakthrough...with,innovative proprietary software. The XS-300(T...
(Date:10/6/2008)...ct. 6 /PRNewswire/ -- The organizers of Informex a...e on Global Sourcing for the,Pharmaceutical Indust...inceton Marriott in New Jersey USA., The conferen... the,Global Sourcing Council, and boasts an unpara...e likes of Johnson & Johnson, Bristol Myers Squibb...
(Date:10/6/2008)... LegalView recently posted detailed inform...he potentially serious side effects caused by the ... the drug,s potential side effects are the develop... for young adult and child patients. , ...- LegalView, the number one resource for everythin...
(Date:10/6/2008)... Hospital Ship Serving in West Africa Rece...Garden Valley, Texas October 6, 2008 -- www.seamob...l provider of communications services to remote lo...s to the FoxNews channel via satellite to Mercy Sh...ica Mercy. The Africa Mercy is the world,s larges...
Breaking Medicine News(10 mins):Health News:Plan Your Breasts in 3-D 2Health News:Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 3Health News:Seamobile Provides Foxnews To Mercy Ships 2Health News:Seamobile Provides Foxnews To Mercy Ships 3...w South Wales may be one of the first scientists t...bipolar disease. Currently there is no single test...searchers who had their paper published in the lat...Research said that this may make the diagnosis of ...
...bidity and mortality in India. An attempt to formu...h has claimed so many young lives, is worth the ex...l trials of a new vaccine for a deadly form of dia...ths annually in India. This move has been accelera...
... system that ranks foods according to the sum of t...ped// by a panel of independent nutritionists, die...y and consumer groups, as well as members of the g...e on Nutrition (SACN). The model developed by th...
...he smoking pot and cigar of the 70s. If you want t...le, just stay on your cell phone and check your e-...n. A study commissioned by Hewlett-Packard shows t...logy, including e-mail and cell phones, can be sli...
Other Medicine News:Health News:Schizophrenia Gets A New Diagnostic Tool 2Health News:Nutrient Profiling System Launched By Food Officials in UK 2Health News:E-Mail Affects Brain More Than Marijuana 2(Date:10/6/2008)...ay Eliminate 6 Weeks of Radiation Therapy -, Event...nternet Wednesday, October 22, 2008, 3 - 4 p.m.... , HAMPTON, Va., Oct. 6 / Questions ...sed with breast cancer in May. Would she have the,...ation or chemotherapy?, , To view the Multimedia...
(Date:10/3/2008)... Jersey is the newest study site, PHILADELPHIA, O...spital,of Philadelphia today received a contract t...,s Study. Children,s Hospital will manage local,pa...rlington County, New,Jersey. The study is funded b...rs anticipate approximately 1,000 families in Burl...
(Date:10/2/2008)...the Results of Rosetta Genomics, microRNA-based,Te...amous From non Squamous non Small Cell Lung C...ed on the miRview(TM) Technology First Approved fo...gh Complexity Molecular Pathology Lab ... is Expecting to Launch miRview(TM) Squamous Later...
(Date:10/2/2008)...RNewswire-FirstCall/ - AEterna Zentaris Inc.,(NASD...company focused on,endocrine therapy and oncology,...ge of patient recruitment for its Phase 2 trial in...ne-releasing hormone (LHRH) agonist,linked to doxo... patient,recruitment was taken following recent fi...
Breaking Medicine Technology:Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 3Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 4Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 5AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 3AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 5Evotec Expands Collaboration With InterMune 3744 1Evotec Expands Collaboration With InterMune 3744 2Evotec Expands Collaboration With InterMune 3744 3High levels of estrogen associated with breast cancer recurrence 2422 1High levels of estrogen associated with breast cancer recurrence 2422 2Secrets of cooperation between trees and fungi revealed 2419 1Secrets of cooperation between trees and fungi revealed 2419 2AHIP Statement on House Passage of Mental Health Parity Legislation 13613 1...,s Oncology Group (COG) Study Presented at,America...HICAGO, June 04, 2007 /PRNewswire-FirstCall/ -- Im...used on developing monoclonal,antibodies to treat ... that treatment with epratuzumab plus standard,che...en with,B-precursor acute lymphoblastic leukemia (...
...t analyses of progression-free survival in,the SPA...ion in,relative risk of disease progression for pa...ded prior Taxotere use,geographies, as well as pr... /PRNewswire-FirstCall/ -- Pharmion,Corporation an...of,additional data from the double-blind, randomiz...
Other Medicine Technology:Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 2Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 3Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 4Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 5Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 2Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 3Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 4Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 5Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 6Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 7...ed for continuous, random access operation, the El...rge volume laboratories that want to maximize prod...mplicity, flexibility and Stat capabilities of the...e changing needs of an aggressive laboratory testi...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t
Sample throughput of up to 80 tests per hour (4 modules). Low maintenance requirements. Continuous random access. 25 - 100 channels on board. 1008 tests or 6 hours of walkaway operation.
The Embla 96/384 well washer is a top-loading, robotic-compatible plate washer for 96- and 384-well microplate washing. It is ideal for ELISAs and most cell applications.
Medicine Products: